Rejoovenate Bio
PrivateCompany Overview
Rejoovenate Bio is a biotechnology company developing laboratory-based solutions to address age-related declines in egg quality and extend female reproductive healthspan.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejoovenate Bio Comparables
Compare Rejoovenate Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| U-Ploid Biotechnologies | 87% | |
| Gameto | 83% | |
| Vitra Labs | 81% |
Rejoovenate Bio Funding Rounds
Historical fundraising activity
Rejoovenate Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rejoovenate Bio's valuation, stock price, and market status.
Is Rejoovenate Bio a public or private company?
Rejoovenate Bio is a private company.
What is the current stock price of Rejoovenate Bio?
Rejoovenate Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Rejoovenate Bio worth (valuation)?
Rejoovenate Bio's valuation is estimated at $67.4M based on funding round data.
Can I buy Rejoovenate Bio stock?
Rejoovenate Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rejoovenate Bio's last funding round?
Rejoovenate Bio's most recent funding round was Series A Extension on April 1, 2026.
Who are the main investors in Rejoovenate Bio?
Key investors in Rejoovenate Bio include Kendall Capital Partners, VCapital.
Will Rejoovenate Bio IPO soon?
No public IPO plans have been announced for Rejoovenate Bio.
How can I track Rejoovenate Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rejoovenate Bio's secondary market activity and sign up for updates.